260 related articles for article (PubMed ID: 21149921)
1. Reduction of herpes simplex virus type-2 replication in cell cultures and in rodent models with peptide-conjugated morpholino oligomers.
Eide K; Moerdyk-Schauwecker M; Stein DA; Bildfell R; Koelle DM; Jin L
Antivir Ther; 2010; 15(8):1141-9. PubMed ID: 21149921
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of HSV-1 ocular infection with morpholino oligomers targeting ICP0 and ICP27.
Moerdyk-Schauwecker M; Stein DA; Eide K; Blouch RE; Bildfell R; Iversen P; Jin L
Antiviral Res; 2009 Nov; 84(2):131-41. PubMed ID: 19665486
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of acyclovir-resistant herpes simplex type 2 isolates in animal models of genital herpes: models for antiviral evaluations.
Bernstein DI; Ireland J; Bourne N
Antiviral Res; 2000 Sep; 47(3):159-69. PubMed ID: 10974368
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo antiherpetic effects of (1R,2R)-1-(5'-methylful-3'-yl)propane-1,2,3-triol.
Sasaki K; Hayashi K; Matsuya Y; Sugimoto K; Lee JB; Kurosaki F; Hayashi T
J Nat Med; 2016 Apr; 70(2):217-24. PubMed ID: 26763002
[TBL] [Abstract][Full Text] [Related]
5. The novel immunosuppressive agent mycophenolate mofetil markedly potentiates the antiherpesvirus activities of acyclovir, ganciclovir, and penciclovir in vitro and in vivo.
Neyts J; Andrei G; De Clercq E
Antimicrob Agents Chemother; 1998 Feb; 42(2):216-22. PubMed ID: 9527762
[TBL] [Abstract][Full Text] [Related]
6. Phenoxazine derivatives suppress the infections caused by herpes simplex virus type-1 and herpes simplex virus type-2 intravaginally inoculated into mice.
Hayashi K; Hayashi T; Miyazawa K; Tomoda A
J Pharmacol Sci; 2010; 114(1):85-91. PubMed ID: 20736512
[TBL] [Abstract][Full Text] [Related]
7. In vitro resistance selection and in vivo efficacy of morpholino oligomers against West Nile virus.
Deas TS; Bennett CJ; Jones SA; Tilgner M; Ren P; Behr MJ; Stein DA; Iversen PL; Kramer LD; Bernard KA; Shi PY
Antimicrob Agents Chemother; 2007 Jul; 51(7):2470-82. PubMed ID: 17485503
[TBL] [Abstract][Full Text] [Related]
8. Morpholino oligomers targeting the PB1 and NP genes enhance the survival of mice infected with highly pathogenic influenza A H7N7 virus.
Gabriel G; Nordmann A; Stein DA; Iversen PL; Klenk HD
J Gen Virol; 2008 Apr; 89(Pt 4):939-948. PubMed ID: 18343835
[TBL] [Abstract][Full Text] [Related]
9. The effect of gramicidin, a topical contraceptive and antimicrobial agent with anti-HIV activity, against herpes simplex viruses type 1 and 2 in vitro.
Bourinbaiar AS; Coleman CF
Arch Virol; 1997; 142(11):2225-35. PubMed ID: 9672588
[TBL] [Abstract][Full Text] [Related]
10. Topical formulations containing Trichilia catigua extract as therapeutic options for a genital and an acyclovir-resistant strain of herpes recurrent infection.
Ribelato EV; Wouk J; Celestino GG; Rodrigues BCD; Darido MLG; Barboza MGL; Botura TJ; de Oliveira MC; de Andrade FG; Lonni AASG; de Mello JCP; da Rocha SPD; Faccin-Galhardi LC
Braz J Microbiol; 2023 Sep; 54(3):1501-1511. PubMed ID: 37338788
[TBL] [Abstract][Full Text] [Related]
11. Genital herpes due to acyclovir-sensitive herpes simplex virus caused secondary and recurrent herpetic whitlows due to thymidine kinase-deficient/temperature-sensitive virus.
Shimada Y; Suzuki M; Shirasaki F; Saito E; Sogo K; Hasegawa M; Takehara K; Phromjai J; Chuhjo T; Shiraki K
J Med Virol; 2007 Nov; 79(11):1731-40. PubMed ID: 17854045
[TBL] [Abstract][Full Text] [Related]
12. Griffithsin and Carrageenan Combination To Target Herpes Simplex Virus 2 and Human Papillomavirus.
Levendosky K; Mizenina O; Martinelli E; Jean-Pierre N; Kizima L; Rodriguez A; Kleinbeck K; Bonnaire T; Robbiani M; Zydowsky TM; O'Keefe BR; Fernández-Romero JA
Antimicrob Agents Chemother; 2015 Dec; 59(12):7290-8. PubMed ID: 26369967
[TBL] [Abstract][Full Text] [Related]
13. Antiviral activity of PHA767491 against human herpes simplex virus in vitro and in vivo.
Hou J; Zhang Z; Huang Q; Yan J; Zhang X; Yu X; Tan G; Zheng C; Xu F; He S
BMC Infect Dis; 2017 Mar; 17(1):217. PubMed ID: 28320320
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of RNA virus infections with peptide-conjugated morpholino oligomers.
Stein DA
Curr Pharm Des; 2008; 14(25):2619-34. PubMed ID: 18991679
[TBL] [Abstract][Full Text] [Related]
15. Role of immediate early protein ICP27 in the differential sensitivity of herpes simplex viruses 1 and 2 to leptomycin B.
Park D; Lengyel J; Rice SA
J Virol; 2013 Aug; 87(16):8940-51. PubMed ID: 23740995
[TBL] [Abstract][Full Text] [Related]
16. In vivo anti-herpes simplex virus activity of a sulfated derivative of Agaricus brasiliensis mycelial polysaccharide.
Cardozo FT; Larsen IV; Carballo EV; Jose G; Stern RA; Brummel RC; Camelini CM; Rossi MJ; Simões CM; Brandt CR
Antimicrob Agents Chemother; 2013 Jun; 57(6):2541-9. PubMed ID: 23507287
[TBL] [Abstract][Full Text] [Related]
17. Antiviral activities of methylated nordihydroguaiaretic acids. 2. Targeting herpes simplex virus replication by the mutation insensitive transcription inhibitor tetra-O-methyl-NDGA.
Chen H; Teng L; Li JN; Park R; Mold DE; Gnabre J; Hwu JR; Tseng WN; Huang RC
J Med Chem; 1998 Jul; 41(16):3001-7. PubMed ID: 9685239
[TBL] [Abstract][Full Text] [Related]
18. Synthetic analogues of bovine bactenecin dodecapeptide reduce herpes simplex virus type 2 infectivity in mice.
Shestakov A; Jenssen H; Hancock RE; Nordström I; Eriksson K
Antiviral Res; 2013 Nov; 100(2):455-9. PubMed ID: 24012999
[TBL] [Abstract][Full Text] [Related]
19. Effective deploying of a novel DHODH inhibitor against herpes simplex type 1 and type 2 replication.
Luganini A; Sibille G; Mognetti B; Sainas S; Pippione AC; Giorgis M; Boschi D; Lolli ML; Gribaudo G
Antiviral Res; 2021 May; 189():105057. PubMed ID: 33716051
[TBL] [Abstract][Full Text] [Related]
20. Comparison of different forms of herpes simplex replication-defective mutant viruses as vaccines in a mouse model of HSV-2 genital infection.
Da Costa XJ; Morrison LA; Knipe DM
Virology; 2001 Sep; 288(2):256-63. PubMed ID: 11601897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
